Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Nucletron Operations B V has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are assigned to 3 distinct examiners and 1 distinct art unit. This indicates that while multiple individuals are reviewing the company's applications, they are all part of the same specialized technical group. The focus on 1 distinct art unit suggests that the company's current patent filings are closely related within the medical device field.
LAMPRECHT, JOEL is the busiest examiner for the company. This examiner is responsible for 1 pending office action. Because there are 3 distinct examiners for 3 pending actions, each examiner is handling a single case. This distribution allows the company to interact with several different examiners while benefiting from the consistent technical oversight of a single art unit. Practitioners can focus on the specific prior art and technical standards prevalent in this 1 distinct art unit while managing the individual preferences of the 3 distinct examiners involved in the prosecution of these matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAMPRECHT, JOEL | 1 | 81.4% | +16.8% |
| DECASTRO, ARIANA JOY LACAY | 1 | 0.0% | +0.0% |
| HONRATH, MARC D | 1 | 74.5% | +31.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720070 | MARKING ARRANGEMENT, MEDICAL DEVICE, AND SYSTEM FOR RECONSTRUCTING A PLANNED TRAJECTORY | LAMPRECHT, JOEL | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18644790 | MODULAR BRACHYTHERAPY APPLICATOR | DECASTRO, ARIANA JOY LACAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17596989 | MARKER FOR MEDICAL IMAGING | HONRATH, MARC D | 49d overdue |
| 18720070 | MARKING ARRANGEMENT, MEDICAL DEVICE, AND SYSTEM FOR RECONSTRUCTING A PLANNED TRAJECTORY | LAMPRECHT, JOEL | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720070 | MARKING ARRANGEMENT, MEDICAL DEVICE, AND SYSTEM FOR RECONSTRUCTING A PLANNED TRAJECTORY | LAMPRECHT, JOEL | — | §103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18644790 | MODULAR BRACHYTHERAPY APPLICATOR | DECASTRO, ARIANA JOY LACAY | 3791 | §102§103 | Non-Final OA | — | Pending | Apr 24, 2024 |
| 17596989 | MARKER FOR MEDICAL IMAGING | HONRATH, MARC D | 3791 | §103 | Final Rejection | 49d overdue | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial